Accelerated Approval pathway for our ST-920 gene therapy product candidate for the treatment of Fabry disease.

Click here to view

Presentation

Poster: Unraveling Impact of Manufacturing Process-Related Stresses on AAV Stability, Aggregation, and DNA Release

Download PDF